tiprankstipranks
Trending News
More News >
Novartis Ag (DE:NOTA)
FRANKFURT:NOTA

Compare Novartis (NOTA) vs. Competitors

Compare
23 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Compare
Top Analysts' Price Target
Smart Score
Follow
Novartis
€125.50
$240.73B
19.02
24.88%
1 Buy
4 Hold
0 Sell
Hold
Merck & Company
$114.18
$282.30B
14.46
20.53%
13 Buy
6 Hold
0 Sell
Moderate Buy
Pfizer
$26.97
$153.36B
18.21
2.98%
7 Buy
12 Hold
2 Sell
Hold
Sanofi
$44.60
$108.56B
12.88
-22.82%
1 Buy
2 Hold
0 Sell
Moderate Buy
AbbVie
$205.07
$362.60B
96.82
-3.25%
15 Buy
7 Hold
0 Sell
Moderate Buy
AstraZeneca
13896.00 p
£215.50B
28.13
17.68%
13 Buy
2 Hold
1 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
DE:NOTA
Novartis
125.50
25.96
26.08%
MRK
Merck & Company
114.18
25.11
28.19%
PFE
Pfizer
26.97
2.60
10.67%
SNY
Sanofi
44.60
-9.60
-17.72%
ABBV
AbbVie
205.07
2.69
1.33%
GB:AZN
AstraZeneca
13,896.00
2,640.17
23.46%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts